This study reveals a novel mechanism by which obesity, through the abundant peritumoral adipocytes characteristic of tumors in obese individuals, promotes cisplatin resistance in osteosarcoma, highlighting the A1BG/NAMPT/PARP1 axis as a promising therapeutic target. Here, PARP1 is linked to Obesity.